Press Releases

PTC is committed to serving the interests of all our stakeholders.
Danya
Living with DMD, Ukraine
danya

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

Aug 06, 2013
PTC THERAPEUTICS TO PRESENT AT WEDBUSH CONFERENCE
PTC THERAPEUTICS TO PRESENT AT WEDBUSH CONFERENCE SOUTH PLAINFIELD, NJ – August 6, 2013 –PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Shane Kovacs, Chief Financial Officer of PTC Therapeutics will present a company overview at the Wedbush Securities Life Sciences Management
Read More
Jun 25, 2013
PTC Therapeutics Closes Initial Public Offering
PTC Therapeutics Closes Initial Public Offering SOUTH PLAINFIELD, NJ – June 25, 2013 – PTC Therapeutics, Inc. (PTC) (NASDAQ: PTCT) today announced the closing of its initial public offering of 9,627,800 shares of common stock at a public offering price of $15.00 per share, before
Read More
Jun 20, 2013
PTC THERAPEUTICS PRICES INITIAL PUBLIC OFFERING
PTC THERAPEUTICS PRICES INITIAL PUBLIC OFFERING SOUTH PLAINFIELD, NJ – June 20, 2013 – PTC Therapeutics, Inc. (PTC) today announced the pricing of its initial public offering of 8,372,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts.
Read More
Apr 23, 2013
PTC THERAPEUTICS APPOINTS MARK ROTHERA AS CHIEF COMMERCIAL OFFICER
PTC THERAPEUTICS APPOINTS MARK ROTHERA AS CHIEF COMMERCIAL OFFICER SOUTH PLAINFIELD, NJ – April 23, 2013 – PTC Therapeutics, Inc. (PTC) today announced the appointment of Mark A. Rothera as Chief Commercial Officer, reporting to Stuart W. Peltz, Ph.D., CEO of PTC Therapeutics. Mr.
Read More